Hahn Kim

Hahn Kim is a co-founder of Chiromics. He was crucial in the development of the proprietary science and technology of Chiromics and currently oversees all of Chiromics' operations and business strategies.

He received his B.S.& M.S (Chemistry) from Seoul National University and received his doctorate in synthetic organic chemistry from Princeton University. Before his current role, he was an NIH/NCI postdoctoral fellow in the MacMillan labs. Dr. Kim is also a co-founder of Crescenta Biosciences, the Founding Director of the Princeton University Small Molecule Screening Center, and an associate member of the Rutgers Cancer Institute of New Jersey.